Sökning: onr:"swepub:oai:gup.ub.gu.se/246191" >
Physiology, pathoph...
Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake
-
Elliott, J. A. (författare)
-
Reynolds, J. V. (författare)
-
- le Roux, Carel W (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för gastrokirurgisk forskning och utbildning,Institute of Clinical Sciences, Department of Gastrosurgical Research and Education
-
visa fler...
-
- Docherty, Neil G. (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för gastrokirurgisk forskning och utbildning,Institute of Clinical Sciences, Department of Gastrosurgical Research and Education
-
visa färre...
-
(creator_code:org_t)
- 2016-10-20
- 2016
- Engelska.
-
Ingår i: Expert Review of Endocrinology & Metabolism. - : Informa UK Limited. - 1744-6651 .- 1744-8417. ; 11:6, s. 475-499
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Introduction: With the increasing prevalence of obesity and its associated comorbidities, strides to improve treatment strategies have enhanced our understanding of the function of the gut in the regulation of food intake. The most successful intervention for obesity to date, bariatric surgery effectively manipulates enteroendocrine physiology to enhance satiety and reduce hunger. Areas covered: In the present article, we provide a detailed overview of the physiology of enteroendocrine control of food intake, and discuss its pathophysiologic correlates and therapeutic implications in both obesity and gastrointestinal disease. Expert commentary: Ongoing research in the field of nutrient sensing by L-cells, as well as understanding the role of the microbiome and bile acid signaling may facilitate the development of novel strategies to combat the rising population health threat associated with obesity. Further refinement of post-prandial satiety gut hormone based therapies, including the development of chimeric peptides exploiting the pleiotropic nature of the gut hormone response, and identification of novel methods of delivery may hold the key to optimization of therapeutic modulation of gut hormone physiology in obesity.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- Gut hormones
- obesity
- appetite
- hunger
- satiety
- glucagon-like peptide 1
- GLP-1
- ghrelin
- peptide YY
- PYY
- oxyntomodulin
- OXM
- bariatric surgery
- body weight
- gastric bypass
- RYGB
- esophagectomy
- gastrectomy
- malnutrition
- weight loss
- anorexia
- surger
- glucagon-like peptide-1
- y gastric bypass
- laparoscopic sleeve
- gastrectomy
- short-bowel syndrome
- high-fat diet
- esophageal
- cancer-surgery
- morbidly obese subjects
- agouti-related protein
- dependent insulinotropic polypeptide
- intestinal glucose-metabolism
- Endocrinology & Metabolism
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas